We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
-1.53%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$23.8B
AUM Growth
-$2.11B
Cap. Flow
-$941M
Cap. Flow %
-3.95%
Top 10 Hldgs %
24.95%
Holding
1,082
New
165
Increased
347
Reduced
405
Closed
129

Sector Composition

Rank Sector Weight
1 Technology 30.74%
2 Financials 13.54%
3 Consumer Discretionary 13.12%
4 Industrials 11.88%
5 Healthcare 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANAB icon
626
AnaptysBio
ANAB
$1.63B
$1.59M 0.01%
28,625
-26,463
-48% -$1.42M
LAW icon
627
CS Disco
LAW
$226M
$1.57M 0.01%
410,894
+247,105
+151% +$1.22M
SIGA icon
628
SIGA Technologies
SIGA
$226M
$1.56M 0.01%
291,846
-204,320
-41% -$1.27M
KOD icon
629
Kodiak Sciences
KOD
$2.57B
$1.56M 0.01%
40,939
-86,291
-68% -$2.23M
ARCT icon
630
Arcturus Therapeutics
ARCT
$165M
$1.53M 0.01%
198,728
-94,322
-32% -$688K
RYZ
631
Ryerson Holding Corp
RYZ
$1.54B
$1.53M 0.01%
68,050
-242,014
-78% -$6.31M
KRO icon
632
KRONOS Worldwide
KRO
$764M
$1.52M 0.01%
231,648
-2,026
-0.9% -$11.5K
TCBK icon
633
TriCo Bancshares
TCBK
$1.89B
$1.51M 0.01%
31,808
+1,554
+5% +$75.9K
RUSHA icon
634
Rush Enterprises Class A
RUSHA
$5.93B
$1.51M 0.01%
+22,812
New +$1.5M
FLXS icon
635
Flexsteel Industries
FLXS
$306M
$1.51M 0.01%
33,528
+9,420
+39% +$437K
RCKT icon
636
Rocket Pharmaceuticals
RCKT
$358M
$1.49M 0.01%
+416,533
New +$1.66M
TLS icon
637
Telos
TLS
$337M
$1.48M 0.01%
354,216
+84,541
+31% +$400K
CHYM
638
Chime Financial
CHYM
$7.91B
$1.48M 0.01%
+78,923
New +$1.79M
AVO icon
639
Mission Produce
AVO
$1.08B
$1.48M 0.01%
107,282
-977
-0.9% -$13K
CLMB icon
640
Climb Global Solutions
CLMB
$467M
$1.47M 0.01%
+74,112
New +$1.92M
CASY icon
641
Casey's General Stores
CASY
$32.4B
$1.46M 0.01%
+2,009
New +$1.31M
PINE
642
Alpine Income Property Trust
PINE
$339M
$1.46M 0.01%
81,158
+14,422
+22% +$268K
THC icon
643
Tenet Healthcare
THC
$17.1B
$1.46M 0.01%
7,719
+6,705
+661% +$1.41M
RBBN icon
644
Ribbon Communications
RBBN
$356M
$1.45M 0.01%
685,310
-204,858
-23% -$490K
UNTY icon
645
Unity Bancorp
UNTY
$571M
$1.45M 0.01%
28,022
+8,289
+42% +$437K
FHTX icon
646
Foghorn Therapeutics
FHTX
$298M
$1.45M 0.01%
303,757
+34,571
+13% +$190K
CNDT icon
647
Conduent
CNDT
$226M
$1.45M 0.01%
1,131,025
-520,447
-32% -$793K
RMNI icon
648
Rimini Street
RMNI
$398M
$1.45M 0.01%
441,329
+142,651
+48% +$495K
EDIT icon
649
Editas Medicine
EDIT
$419M
$1.44M 0.01%
582,309
-244,831
-30% -$518K
INSG icon
650
Inseego
INSG
$115M
$1.43M 0.01%
128,166
+9,946
+8% +$112K

Similar funds

Jacobs Levy Equity Management's Q1 2026 Portfolio in Review

As of Q1 2026, Jacobs Levy Equity Management held 1,082 positions worth $23.8B, down 8.1% from $25.9B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Jacobs Levy Equity Management withdrew a net $941M in Q1 2026, closing 129 positions and reducing 405 holdings. Its most notable exit was Illumina, an estimated $53.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Jacobs Levy Equity Management opened a new position in Texas Instruments worth $166M.

  • Jacobs Levy Equity Management's largest Q1 2026 buy was Texas Instruments: 857,024 shares worth $166M.
  • Jacobs Levy Equity Management added most to Alphabet (Google) Class C in Q1 2026, an estimated $293M increase.
  • Jacobs Levy Equity Management's biggest Q1 2026 reduction was Lam Research, cutting an estimated $284M.
  • Jacobs Levy Equity Management fully exited Illumina in Q1 2026, selling an estimated $53.1M.
  • Jacobs Levy Equity Management's ten largest holdings make up 25% of its $23.8B portfolio in Q1 2026.
  • Jacobs Levy Equity Management opened 165 new positions and closed 129 in Q1 2026.
  • Jacobs Levy Equity Management's portfolio value fell 8.1% quarter-over-quarter to $23.8B.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.